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Background Most patients with amyotrophic lateral
sclerosis (ALS) are treated with mechanical insufflation–
exsufflation (MI-E) in order to improve cough. This
method often fails in ALS with bulbar involvement,
allegedly due to upper-airway malfunction. We have
studied this phenomenon in detail with laryngoscopy to
unravel information that could lead to better treatment.
Methods We conducted a cross-sectional study of 20
patients with ALS and 20 healthy age-matched and sex-
matched volunteers. We used video-recorded flexible
transnasal fibre-optic laryngoscopy during MI-E
undertaken according to a standardised protocol,
applying pressures of ±20 to ±50 cm H2O. Laryngeal
movements were assessed from video files. ALS type and
characteristics of upper and lower motor neuron
symptoms were determined.
Results At the supraglottic level, all patients with ALS
and bulbar symptoms (n=14) adducted their laryngeal
structures during insufflation. At the glottic level, initial
abduction followed by subsequent adduction was observed
in all patients with ALS during insufflation and exsufflation.
Hypopharyngeal constriction during exsufflation was
observed in all subjects, most prominently in patients with
ALS and bulbar symptoms. Healthy subjects and patients
with ALS and no bulbar symptoms (n=6) coordinated their
cough well during MI-E.
Conclusions Laryngoscopy during ongoing MI-E in
patients with ALS and bulbar symptoms revealed laryngeal
adduction especially during insufflation but also during
exsufflation, thereby severely compromising the size of the
laryngeal inlet in some patients. Individually customised
settings can prevent this and thereby improve and extend
the use of non-invasive MI-E.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is an incurable
and highly disabling neurodegenerative disease of
upper and lower motor neurons. Treatment is
largely symptomatic, and average life expectancy at
the time of the diagnosis is 2–3 years unless ventila-
tory assistance is provided.1
ALS is classified as ‘spinal’ if symptom onset
affects the limbs predominantly, and as ‘bulbar’ if
the disease presents with difficulty in speaking,
swallowing or coughing. Paresis to predominantly
upper motor neurons leads primarily to spasticity,
whereas paresis of lower motor neurons leads to
flaccidity.2 Regardless of the subtype, ALS pro-
gresses and eventually encompasses all skeletal
muscles.3 Involvement of respiratory muscles limits
respiratory function and cough, thereby leading to
secretion accumulation, lung infections and, even-
tually, respiratory failure.3–6 Effective augmentation
of cough is vital for clearance of airway secretions
in these patients and fundamental for the preven-
tion and treatment of pneumonias.6 7
In a voluntary cough, inspiratory muscles increase
the lung volume, laryngeal muscles coordinate
opening and closure of the glottis and expiratory
muscles increase the thoracoabdominal pressure.8
These interactions are disturbed in neuromuscular
disorders.7 9 Mechanical insufflation-exsufflation
(MI-E) is used widely to assist cough mechanically
by applying positive and negative pressure changes
to the airways, either non-invasively via a mask or
invasively via a tracheostomy.10 11 It has been
hypothesised that coordinated glottic movements are
required for MI-E to be effective.12 Non-invasive
MI-E can be difficult to apply in patients with the
Key messages
What is the key question?
▸ Mechanical insufflation–exsufflation (MI-E) is
an efficient tool used to improve cough in most
patients with neuromuscular disorders, but the
method often fails when bulbar involvement is
present.
What is the bottom line?
▸ We used laryngoscopy during ongoing MI-E
and saw that patients with bulbar amyotrophic
lateral sclerosis (ALS) were prone to adduct
laryngeal structures throughout the various
pressure cycles, thereby severely obstructing the
airflow and the effect of the treatment.
Why read on?
▸ In patients with bulbar ALS, cough assistance
with MI-E should be delivered carefully and
according to the criteria suggested in the
present study.
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bulbar subtype of ALS. This problem may be due to dysfunction
of bulbar-innervated muscles, but the basic mechanisms are not
understood.
The laryngeal response to MI-E in patients with ALS has
never been studied. Here, we investigated the laryngeal response
patterns to MI-E in ALS to improve the treatment that we can
offer to these severely ill patients.
METHODS
Neurological assessment and definitions
ALS was diagnosed by a senior neurologist (O-BT) in accord-
ance with the revised criteria set by the El Escorial World
Federation of Neurology.13 14 The disease was classified as
‘spinal ALS’, ‘ALS with progressive bulbar palsy’ (hypotonic
bulbar onset with dysarthria, tongue atrophy and absence of jaw
reflex) or ‘ALS with pseudobulbar palsy’ (spastic bulbar onset
with dysarthria, exaggerated jaw reflex and no tongue atrophy).
Patients were assessed using the ALS Functional Rating Scale-
revised (ALSFRS-r).15 Bulbar impairment score (BIS) was evalu-
ated from the ALSFRS-r, from where the items of speech and
swallowing were calculated.16 Dysphagia was determined using
the 100 mL water swallow test.17 18
Subjects
This was a cross-sectional observational population-based study
of 20 patients with ALS who had not undergone tracheostomy
and 20 neurologically healthy age-matched and sex-matched
controls. Exclusion criteria were age <18 years, history of laryn-
gospasm, sensitisation to Xylocain (anaesthetic used during
laryngoscopy), pneumothorax, additional lung disease, cancer,
acute infection of the chest 1 month before study commence-
ment and mental instability.
Approximately 20 patients with ALS who have not undergone
tracheostomy are usually enrolled at all times at the ALS clinic
at Haukeland University Hospital (Bergen, Norway), which
serves a population of ≈500 000 inhabitants. At the start of this
study, 17 patients were enrolled at the clinic and 20 new
patients were diagnosed and enrolled during the 1.5-year
recruitment period from December 2011 to June 2013. All 37
patients were informed about the study and invited to partici-
pate. Thirteen patients declined and four died soon after being
invited, leaving 20 participants. Reasons for non-participation
were severe disease/fatigue (n=7), or limb-onset ALS without
bulbar symptoms and, therefore, no interest in participation
(n=6). The study protocol was approved by the Regional
Committee for Medical Research Ethics. Written informed
consent was obtained from all participants.
Pulmonary function and respiratory strength
Spirometry was undertaken with a Vmax 22 Encore system
(SensorMedics, Yorba Linda, California, USA). FVC, FEV1 and
peak expiratory flow were measured seated, with a nose clip.
Slow vital capacity was measured with a Respirometer (nSpire
Health, Hertford, UK). Peak cough flow was measured using a
hand-held Peak Flow Meter (Vitalograph, Ennis, Ireland).
Plateau values (average of 1 s) of the maximal inspiratory (Pimax)
and expiratory (Pemax) muscle strength and sniff nasal inspira-
tory pressure (SNIP) were measured seated using a Respiratory
Pressure Meter (Micro RPM; Micro Medical, Rochester, UK).
SNIP was measured at functional residual capacity, Pimax at
residual volume and Pemax at total lung capacity. The highest
value from three or more attempts was selected for analyses and
standardised to predicted percentages.19–22
Video-recorded transnasal fibre-optic laryngoscopy during
MI-E
Video-recorded transnasal fibre-optic laryngoscopy (ENF-P3;
Olympus, Tokyo, Japan) was used to visualise laryngeal anatomy
at baseline and response patterns during MI-E (Cough Assist;
Respironics, Murrysville, Pennsylvania, USA). We used a set-up
described in detail previously, except that the laryngoscope was
supported manually (see online supplementary figure S1)
instead of using a customised headgear.23 A standardised MI-E
protocol was used.23 The protocol comprised 12 intervention
arms with various combinations of pressures, instructions and
manual thoracic thrust (see online supplementary table S2).
Pressures of ±20, ±30, ±40 and ±50 cm H2O were used
with specific instructions. For MI-E in automated mode with 2 s
insufflation, 2 s exsufflation and 1 s pause, the instructions were
to ‘inhale’ actively when insufflation was started and to (A)
‘exhale’ or (B) ‘cough’ actively when the device switched to
exsufflation. For MI in manual mode with 2 s insufflation fol-
lowed by manually assisted thoracic thrust, the instructions were
to ‘inhale’ actively when insufflation was started and to ‘cough’
actively during the thoracic thrust.
In case of patient discomfort, the procedure was stopped and
higher examination pressures were not applied.
Analyses of observations
Altogether, 480 recordings were scheduled for assessment, that
is, one recording from 12 intervention arms in 20 patients and
20 control subjects. With respect to assessment of observations,
MI-E cycles were edited into three phases of interest: (i) insuf-
flation, (ii) pressure drop (from positive to negative) and (iii)
active exsufflation or the voluntary cough with no negative pres-
sure applied. The onset and offset of each phase were observed
and defined from the parallel video recording of the MI-E man-
ometer.23 Video recordings were assessed systematically, as
described previously,23 by two trained raters (TA and AKB).
Main features were described at glottic, supraglottic and hypo-
pharyngeal levels (see online supplementary figure S3).
Laryngeal anatomy and motion at rest were evaluated by a
senior laryngologist ( J-HH).
Statistical analyses
The χ2 test, or Fisher’s exact test if expected cell counts were
less than five, were applied to assess differences between groups
with regard to categorical data. Background data were given as
group means with SDs. The number of subjects with the
described patterns of laryngeal movements during MI-E was
given as group counts and percentages. Statistical analyses were
conducted using SPSS V.21.0 (IBM, Armonk, USA). The two-
sided significance level was set at 0.05.
RESULTS
Patient characteristics
Of 20 participating patients with ALS, six had limb onset with
no bulbar symptoms and 14 had bulbar symptoms (table 1); of
these, seven had pseudobulbar (spastic) ALS and seven had pro-
gressive bulbar (hypotonic) ALS. Lung-function characteristics in
ALS were lower than predicted (table 1). In patients with pro-
gressive bulbar ALS, 4/7 subjects had an abnormal epiglottis:
three had a juvenile and high-standing epiglottis, and in one
patient the epiglottis was considered ‘floppy’. Retention of
secretions/sputum was observed in 4/7 patients with progressive
bulbar ALS, in 2/7 cases with pseudobulbar ALS, in 2/6 subjects
with non-bulbar ALS and in 1/20 healthy controls.
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Laryngeal response to MI-E
In total, 453 (94%) of 480 scheduled recordings were analysed.
Four patients with bulbar symptoms completed only parts of
the MI-E protocol due to discomfort from the applied pres-
sures, that is, one patient (progressive bulbar ALS) interrupted
the protocol after pressures of ±20 cm H2O (missing 9/12 inter-
vention arms), one patient (pseudobulbar ALS) after
±30 cm H2O (missing 6/12 intervention arms) and two patients
(one pseudobulbar and one progressive bulbar ALS) after
±40 cm H2O (both patients missing 3/12 intervention arms).
Technical failures led to loss of video recordings in one healthy
control at examining pressures of ±40 and ±50 cm H2O
(missing 6/12 intervention arms).
In general, the larynx moved downwards during applied insuf-
flation and upwards (cranially) during exsufflation. (See table 2
for overall descriptions and online supplementary video 1 for the
laryngeal response in a patient with non-bulbar ALS; online
supplementary video 2 in a healthy control; online supplemen-
tary video 3 in a patient with progressive bulbar ALS; online
supplementary video 4 in a patient with pseudobulbar ALS.)
Adequate laryngeal control was defined as described for normal
cough in the literature,8 and presented as initial abduction of the
true vocal folds (TVF) and aryepiglottic folds (AEF), and there-
after glottic closure with subsequent rapid opening when cough-
ing, abduction of the TVF and AEF followed by sequential
closures and/or narrowing in the exhalation phase of the cough.
Response at the glottic level
Observations at the glottic level were not possible in some patients
with ALS and bulbar symptoms, because adduction of AEF and/or
the hypopharyngeal area obscured the view of TVF, particularly in
the high-pressure ranges of 40–50 cm H2O. Observations at the
glottic level were based on successful visualisation of MI-E cycles
(TVF responses A, B, G, I, M, S, N1, N2 and N3 in figure 1 and
online supplementary tables S4, S5 and S6).
There were significant differences between patients with ALS
and healthy controls with respect to TVF adduction subsequent
to the initial abduction during insufflation (response B in figure 1
and in online supplementary table S4) and exsufflation. Varying
the instructions (to cough or exhale during negative pressures or
to cough without applied negative pressure) did not influence the
groups differently (response N1, N2 and N3 in figure 1 and
online supplementary table S6).
Response at the supraglottic level
AEF responses are presented as C, D, H, J, O and P (figure 2
and online supplementary tables S4, S5 and S6). Medial rotation
of the cuneiform tubercles accompanied by considerable adduc-
tion of the AEF was observed during insufflation (initially or
subsequent to abduction) in all patients with bulbar ALS (online
supplementary table S4 and response C and D in figure 2).
A retroflex movement of epiglottis (a passive dorsal rotation)
was observed to partly occlude the laryngeal inlet in some cases,
either as a rapid movement or lasting throughout the insuffla-
tion (responses E, K and Q (figure 2 and online supplementary
tables S4, S5 and S6)).
Oesophageal opening was observed during insufflation in two
patients with progressive bulbar ALS. Both subjects were
observed to burp afterwards, suggesting that (part of) the insuf-
flation volume ended up in the oesophagus and stomach instead
of the lungs.
Response at the tongue base and at the hypopharyngeal
level
There were significant differences between healthy controls and
patients with ALS with regard to backward movement of the
tongue base during insufflation and during the pressure drop
(responses F and L in figure 3 and online supplementary tables
S4 and S5).
Constriction of the hypopharynx during exsufflation was
observed in healthy controls and in patients with ALS, regard-
less of the presence of bulbar symptoms. In patients with ALS
and bulbar symptoms, hypopharyngeal constriction was more
prominent in those with progressive bulbar paresis. The
Table 1 Background characteristics of the study participants (n=40)





Male/female ratio 13/7 13/7 6/0 7/7
Age, years 66.9 (7.2) 68.7 (9.3) 65.8 (9.2) 69.9 (9.4)
BMI, kg/m2 23.9 (2.4) 23.6 (4.3) 23.5 (1.8) 23.6 (5.1)
FVC, % pred 113.6 (16.0) 67.4 (22.1) 73.5 (18.8) 64.5 (23.7)
FEV1, % pred 107.4 (19.0) 70.6 (25.7) 76.0 (22.0) 68.1 (27.7)
SVC, L 4.15 (1.3) 2.92 (1.0) 3.6 (0.7) 2.6 (1.0)
SVC, % pred 110.6 (20.1) 76.1 (22.5) 78.7 (12.9) 75.0 (26.2)
PCF, L/min 484.5 (130.2) 266.8 (145.8) 340.8 (198.6) 232.6 (108.4)
Pimax, cm H2O 95.2 (23.6) 43.3 (20.9) 54.2 (18.9) 38.6 (20.5)
Pimax, % pred 111.3 (24.9) 52.9 (23.7) 58.3 (20.6) 50.6 (25.2)
Pemax, cm H2O 140.8 (37.9) 50.4 (30.0) 80.2 (32.1) 37.6 (18.3)
Pemax, % pred 140.1 (34.3) 49.4 (24.8) 68.2 (30.3) 41.3 (17.6)
SNIP, cm H2O 91.2 (33.7) 38.6 (17.9) 47.7 (22.2) 33.6 (13.8)
SNIP, % pred 99.1 (34.6) 42.6 (19.0) 48.1 (22.9) 39.7 (16.9)
WST, mL/s 31.50 (7.7) 12.3 (11.4) 25.8 (7.6) 5.5 (4.9)
ALSFRS-r – 36.7 (8.4) 39.0 (7.5) 35.6 (8.9)
BIS – 6.0 (2.3) 8.0 (0) 5.0 (2.3)
Figures are group means with SDs.
ALS, amyotrophic lateral sclerosis; ALS Functional Rating Scale-revised; BIS, bulbar impairment scale; BMI, body mass index; PCF, peak cough flow; Pemax, maximal expiratory mouth
pressure; Pimax, maximal inspiratory mouth pressure; SNIP, sniff nasal inspiratory pressure; SVC, slow vital capacity; WST, water swallow test.
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hypopharynx was totally constricted in 4/7 patients with pro-
gressive bulbar paresis and in 1/7 patients with pseudobulbar
paresis (responses R1, R2 and R3 in figure 3 and online
supplementary table S6).
Differences in laryngeal movements between patients with
pseudobulbar and progressive bulbar ALS were not significant.
A few significant values were observed between observations of
healthy controls and patients with ALS and bulbar symptoms,
and between patients with ALS with and without bulbar
symptoms. Due to a multiple-testing problem, these results
should be interpreted with caution. However, we saw a pattern
in comparison between controls and patients with ALS and
bulbar symptoms with regard to backward movement of the
tongue base during the pressure drop and in subsequent adduc-
tion of TVF during exsufflation (see online supplementary
tables S4–S6).
DISCUSSION
This is the first study to show that video-recorded flexible laryn-
goscopy is a feasible method to characterise laryngeal responses
throughout MI-E in patients with ALS. Results clearly indicated
that MI-E in patients with bulbar symptoms was associated with
adduction of supraglottic laryngeal structures during insuffla-
tion, and that this seemed to compromise airflow. Backward
movement of the tongue base during insufflation, potentially
obstructing airflow at the hypopharynx, was more prominent in
patients with ALS than in healthy controls. Moreover, patients
with ALS, irrespective of subtype, were more likely to adduct
the vocal folds during insufflation and exsufflation. Patients with
ALS, without bulbar symptoms, could cough in a coordinated
way, similar to that seen in healthy controls.
The main strength of this study was provision of important
knowledge on a challenging clinical problem achieved using
objective and verifiable methods in a population-based sample
of patients whose data were compared with those of healthy
matched volunteers. The small study cohort was a limitation,
complicating statistical handling and rendering the study at risk
of particularly type-II errors (ie, failure to detect significant dif-
ferences that may have been present). A priori power calculation
could not be undertaken, because the data distribution was not
known when planning the study.24
Transnasal fibre-optic laryngoscopy during ongoing MI-E in
patients with ALS has not been described previously, but has
been used to describe the larynx during simple tasks (eg, vocalis-
ing, spontaneous cough and forced exhalation).25 26 We
encountered some technical challenges. First, as the larynx
moved downwards and upwards during insufflation and exsuf-
flation, dynamic adjustments of the laryngoscope position were
required. Sometimes, airway secretions led to poor-quality video
recordings, and pretreatment aiming to clear secretions could
have been considered. Adduction of supraglottic structures pre-
cluded visual access to the vocal folds in some patients.
The present study suggests that adduction of primarily supra-
glottic laryngeal structures during insufflation may be a critical
issue when carrying out MI-E in patients with ALS and bulbar
symptoms. Conceivably, the observed adduction prevents lung
insufflation before exsufflation, thereby compromising the effect
of MI-E. We cannot explain these response patterns, but can only
speculate. There is only one abductor muscle in the larynx, the
posterior cricoarytenoid muscle, but several small intrinsic
adductors.27 Intrinsic laryngeal muscles interact in a complex
way during cough, speech and swallowing, but always act in
concert. Stimulation of extremely sensitive receptors in the supra-
glottic larynx usually induces complex adductor reflexes that, for
example, prevent foreign bodies from entering the airways.27
This reflex circuit may be hyper-responsive or dysregulated in
patients with ALS and, therefore, lead to inappropriate laryngeal
closure, comparable with the observations made in patients with
Parkinson’s disease or brainstem compression.28 29 Tomik et al25
observed early dysfunction of the vagal nerve before any clinical
signs of bulbar dysfunction in patients with spinal ALS. The
observed vocal fold adduction in our study supports this finding.
Differences in the two subtypes of bulbar ALS may influence
laryngeal response patterns to MI-E, that is, progressive (hypo-
tonic) versus pseudobulbar (spastic) ALS. In pseudobulbar ALS,
laryngeal adduction occurred mainly at the glottic level at rela-
tively high insufflation pressures. It seems reasonable to suggest
that positive pressures more easily trigger laryngeal adductor
reflexes in a disease that is predominantly spastic. AEF are rela-
tively soft structures provided with only scattered muscle fibres.
Therefore, adduction at the supraglottic level could, theoretically,
be explained by the Bernoulli principle: increasing airflow initiates
negative intraluminal pressures that eventually cause medial col-
lapse.30 This mechanism may conceivably be particularly import-
ant in progressive bulbar ALS characterised predominantly by
hypotonic paresis. An abnormal high-standing epiglottis may have
a practical implication by compromising the laryngeal inlet during
insufflation due to retroflex movements caused by the positive
pressures, as demonstrated also during treatment with CPAP in
patients with obstructive sleep apnoea.31
Table 2 Description of laryngeal response patterns during the MI-E protocol (n=40)
Glottic level Supraglottic level Tongue base and hypopharyngeal level
Subjects (N=20) True vocal folds (TVF) Aryepiglottic folds (AEF) Epiglottis (EG)
Base of the
tongue (BT) Hypopharynx (HP)




















Backward in 5/7 Constriction in all, and
very narrow in 4/7
Pseudobulbar ALS
(n=7)
Inadequate control§ in insufflation;
in 3/7and in 1/7 in exsufflation
Adduction in insufflation in all
(but in 4/7, only at higher





Constriction in all, and
very narrow in 1/7
*Normal cough, that is, TVF abduction in insufflation, glottic closure when coughing and TVF abduction+sequential closures and/or narrowing in exsufflation.
†AEF follows the movements of the TVF.
§Very small TVF opening in insufflation or in exsufflation.
ALS, amyotrophic lateral sclerosis; MIE, mechanical insufflation–exsufflation.
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Hypopharyngeal constriction during exsufflation was
observed to varying extents in all study subjects, as well as
healthy controls. This finding confirms reports of upper-airway
narrowing at pharyngeal and oropharyngeal levels upon appli-
cation of negative pressures during exhalation in healthy sub-
jects.32–34 This phenomenon has been used to explain the
Figure 1 Laryngeal response at the glottic level. Figures are percentages of the sample with the described response. *Significant difference
between healthy volunteers and patients with ALS. ALS, amyotrophic lateral sclerosis; TVF, true vocal folds.
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ineffectiveness of MI-E in patients with ALS.35 Sancho et al
undertook CT during MI-E at baseline and during exsufflation
in three patients with ALS. They reported varying reductions
of the lateral diameter at the level of nasopharynx, uvula and
pharynx during the exsufflation phase at −40 cm H2O.12 The
response during insufflation was not examined. They suggested
Figure 2 Laryngeal response at the supraglottic level. Figures are percentages of the sample with the described response.*Significant difference
between healthy volunteers and patients with ALS. AEF, aryepiglottic folds; ALS, amyotrophic lateral sclerosis.
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that MI-E should be carried out by applying a single insuffla-
tion followed by a manually assisted cough instead of active
exsufflation with negative pressures.35 36 Hypopharyngeal con-
striction during exsufflation was observed in healthy controls
and patients with ALS in the present study; so, this phenom-
enon alone cannot explain treatment failure in bulbar ALS.
Moreover, inability to fill the lungs during insufflation because
of the observed supraglottic adduction would create a vacuum
during the subsequent active exsufflation, and thereby aggravate
hypopharyngeal constriction. If this hypothesis is correct, a
single insufflation followed by a manually assisted cough
cannot help patients with bulbar ALS to cough more effect-
ively, but will be both uncomfortable and unproductive.
The present study suggests that an individual approach to
MI-E used in respiratory airway therapy is highly important.
Lower positive pressures and airflow combined with longer
inspiratory times may contribute to better laryngeal stability
during insufflation, perhaps by preventing or reducing the impact
of protective laryngeal reflex circuits and the intraluminal suction
forces induced by the Bernoulli effect (figure 4). Patients with
bulbar insufficiency may, therefore, be more likely to obtain suffi-
cient inspiratory volumes, a situation that would improve the
conditions for exsufflation of the lungs. The phasic relationship
that exists between the posterior cricoarytenoid muscle and dia-
phragm is a feature that could, theoretically, be exploited clinic-
ally. That is, when the diaphragm contracts, the activity of the
posterior cricoarytenoid muscle increases in a coordinated
manner due to vagal stimulation, thereby abducting the larynx.27
If the patient is instructed to inhale actively before active insuffla-
tion with MI-E, this act would, theoretically, lead to better laryn-
geal abduction and facilitate airflow. Recently, MI-E devices with
a ‘trigger’ function linked to insufflation have become available,
and these mechanisms should be studied closely.
A better understanding of laryngeal dysfunction as ALS pro-
gresses in its various phenotypes can help establish better (and
hopefully individually tailored) clinical respiratory treatment
strategies for these patients, and perhaps also for other patients
with bulbar-innervated muscle dysfunction.
CONCLUSION
Video-recorded flexible laryngoscopy is a feasible method to
characterise laryngeal responses throughout an MI-E protocol in
patients with ALS. Treatment failure with MI-E in patients with
bulbar symptoms is likely to be caused primarily by laryngeal
adduction during insufflation, predominantly at the supraglottic
level. This response precludes air-filling of the lungs during
Figure 3 Laryngeal response at the tongue base and hypopharyngeal level. Figures are percentages of the sample with the described response.
*Significant difference between healthy volunteers and patients with amyotrophic lateral sclerosis (ALS).
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insufflation, causing discomfort and subsequent inefficient
exsufflation. We propose that individually customised settings
for pressure and flow can improve and extend the use of non-
invasive MI-E in ALS, and that flexible laryngoscopy can be an
efficient tool in this respect in selected patients who do not
respond as expected.
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